CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER
- 1 August 2001
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 81 (4) , 871-883
- https://doi.org/10.1016/s0039-6109(05)70171-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian CancerGynecologic Oncology, 1999
- Stage IV Ovarian Cancer: Impact of Surgical Debulking1Gynecologic Oncology, 1997
- Epithelial Ovarian Carcinoma: Principles of Primary SurgeryGynecologic Oncology, 1994
- The impact of subspecialty training on the management of advanced ovarian cancerGynecologic Oncology, 1992
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinomaGynecologic Oncology, 1989
- 7 The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancerBailliere's Clinical Obstetrics and Gynaecology, 1989
- Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancerGynecologic Oncology, 1985
- Stage III epithelial ovarian cancer: The role of maximal surgical reductionGynecologic Oncology, 1984
- Debulking surgery: Does it increase the quality of survival?Gynecologic Oncology, 1982